These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34651395)

  • 21. SARS-CoV-2 and type 1 diabetes in children in Finland: an observational study.
    Knip M; Parviainen A; Turtinen M; But A; Härkönen T; Hepojoki J; Sironen T; Iheozor-Ejiofor R; Uğurlu H; Saksela K; Lempainen J; Ilonen J; Vapalahti O;
    Lancet Diabetes Endocrinol; 2023 Apr; 11(4):251-260. PubMed ID: 36958868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy.
    Gadani SP; Reyes-Mantilla M; Jank L; Harris S; Douglas M; Smith MD; Calabresi PA; Mowry EM; Fitzgerald KC; Bhargava P
    EBioMedicine; 2021 Nov; 73():103636. PubMed ID: 34666226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency of Autoantibody-Negative Type 1 Diabetes in Children, Adolescents, and Young Adults During the First Wave of the COVID-19 Pandemic in Germany.
    Kamrath C; Rosenbauer J; Tittel SR; Warncke K; Hirtz R; Denzer C; Dost A; Neu A; Pacaud D; Holl RW
    Diabetes Care; 2021 Jul; 44(7):1540-1546. PubMed ID: 33990377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Symptoms and Glycemic Control in Young People With Type 1 Diabetes Following SARS-CoV-2 Infection: An Observational Study.
    Nimri R; Rachmiel M; Yackobovitch-Gavan M; Brener A; de Vries L; Fisch Shvalb N; Lazar L; Oren A; Jacobi-Polishook T; Shefer Averbuch N; Tenenbaum A; Mel E; Krepel Volsky S; Mouler M; Demol S; Shalitin S; Bello R; Phillip M; Lebenthal Y
    J Clin Endocrinol Metab; 2022 Jul; 107(8):e3264-e3272. PubMed ID: 35524727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New-onset type 1 diabetes and severe acute respiratory syndrome coronavirus 2 infection.
    Anindya R; Rutter GA; Meur G
    Immunol Cell Biol; 2023 Mar; 101(3):191-203. PubMed ID: 36529987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased frequency of severe diabetic ketoacidosis at type 1 diabetes onset among children during COVID-19 pandemic lockdown: an observational cohort study.
    Dżygało K; Nowaczyk J; Szwilling A; Kowalska A
    Pediatr Endocrinol Diabetes Metab; 2020; 26(4):167-175. PubMed ID: 33554490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current Evidence on the Efficacy of Gluten-Free Diets in Multiple Sclerosis, Psoriasis, Type 1 Diabetes and Autoimmune Thyroid Diseases.
    Passali M; Josefsen K; Frederiksen JL; Antvorskov JC
    Nutrients; 2020 Aug; 12(8):. PubMed ID: 32752175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production.
    Maier LM; Lowe CE; Cooper J; Downes K; Anderson DE; Severson C; Clark PM; Healy B; Walker N; Aubin C; Oksenberg JR; Hauser SL; Compston A; Sawcer S; ; De Jager PL; Wicker LS; Todd JA; Hafler DA
    PLoS Genet; 2009 Jan; 5(1):e1000322. PubMed ID: 19119414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple autoimmune-associated variants confer decreased IL-2R signaling in CD4+ CD25(hi) T cells of type 1 diabetic and multiple sclerosis patients.
    Cerosaletti K; Schneider A; Schwedhelm K; Frank I; Tatum M; Wei S; Whalen E; Greenbaum C; Kita M; Buckner J; Long SA
    PLoS One; 2013; 8(12):e83811. PubMed ID: 24376757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin D-independent benefits of safe sunlight exposure.
    Erem AS; Razzaque MS
    J Steroid Biochem Mol Biol; 2021 Oct; 213():105957. PubMed ID: 34329737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2 Infections and Presymptomatic Type 1 Diabetes Autoimmunity in Children and Adolescents From Colorado, USA, and Bavaria, Germany.
    Rewers M; Bonifacio E; Ewald D; Geno Rasmussen C; Jia X; Pyle L; Ziegler AG;
    JAMA; 2022 Sep; 328(12):1252-1255. PubMed ID: 35930271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 in patients with multiple sclerosis undergoing disease-modifying treatments.
    Laroni A; Schiavetti I; Sormani MP; Uccelli A
    Mult Scler; 2021 Dec; 27(14):2126-2136. PubMed ID: 33205695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical heterogeneity of type 1 diabetes (T1D) found in Asia.
    Park Y; Wintergerst KA; Zhou Z
    Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28544229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type 1 diabetes mellitus and multiple sclerosis: common etiological features.
    Handel AE; Handunnetthi L; Ebers GC; Ramagopalan SV
    Nat Rev Endocrinol; 2009 Dec; 5(12):655-64. PubMed ID: 19884899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Navigating the landscape of COVID-19 for Multiple Sclerosis patients and clinicians.
    Dyczkowska K; Kalinowska-Łyszczarz A
    Neurol Neurochir Pol; 2023; 57(1):90-100. PubMed ID: 36727546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple sclerosis and type 1 diabetes in Sardinia.
    de Craen AJ; Huizinga TW; Westendorp RG
    Lancet; 2002 Oct; 360(9341):1253. PubMed ID: 12401282
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of Different Disease-Modifying Therapies on Humoral Response to BNT162b2 Vaccine in Sardinian Multiple Sclerosis Patients.
    Pitzalis M; Idda ML; Lodde V; Loizedda A; Lobina M; Zoledziewska M; Virdis F; Delogu G; Pirinu F; Marini MG; Mingoia M; Frau J; Lorefice L; Fronza M; Carmagnini D; Carta E; Orrù V; Uzzau S; Solla P; Loi F; Devoto M; Steri M; Fiorillo E; Floris M; Zarbo IR; Cocco E; Cucca F
    Front Immunol; 2021; 12():781843. PubMed ID: 34956211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "One and a Half Years of Things We Could Have Done": Multi-Method Analysis of the Narratives of Adolescents with Type 1 Diabetes during the COVID-19 Pandemic.
    Tremolada M; Cusinato M; D'Agnillo A; Negri A; Righetto E; Moretti C
    Int J Environ Res Public Health; 2023 Feb; 20(3):. PubMed ID: 36767985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered expression of SIRPγ on the T-cells of relapsing remitting multiple sclerosis and type 1 diabetes patients could potentiate effector responses from T-cells.
    Sinha S; Renavikar PS; Crawford MP; Steward-Tharp SM; Brate A; Tsalikian E; Tansey M; Shivapour ET; Cho T; Kamholz J; Karandikar NJ
    PLoS One; 2020; 15(8):e0238070. PubMed ID: 32853219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A one year follow of patients with multiple sclerosis during COVID-19 pandemic: A cross-sectional study in Qom province, Iran.
    Paybast S; Hejazi SA; Molavi P; Habibi MA; Naser Moghadasi A
    Mult Scler Relat Disord; 2022 Apr; 60():103712. PubMed ID: 35247752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.